268 related articles for article (PubMed ID: 6268343)
1. The diagnosis of renal osteodystrophy: a comparison of Technetium-99m-pyrophosphate bone scintigraphy with other techniques.
Hodson EM; Howman-Giles RB; Evans RA; Bautovich G; Hills EE; Sherbon K; Bach BD; Horvath JS; Tiller DJ
Clin Nephrol; 1981 Jul; 16(1):24-8. PubMed ID: 6268343
[TBL] [Abstract][Full Text] [Related]
2. Bone scintigraphy in renal osteodystrophy.
de Graaf P; Schicht IM; Pauwels EK; te Velde J; de Graeff J
J Nucl Med; 1978 Dec; 19(12):1289-96. PubMed ID: 104017
[TBL] [Abstract][Full Text] [Related]
3. [The bony scan at 99m Tc pyrophosphate in the chronic kidney deficiency treated by hemodialysis (author's transl)].
Cledes J; Paille R; Jacolot G; Morin JF; Caroff J
Sem Hop; 1980 Jan 8-15; 56(1-2):7-10. PubMed ID: 6244634
[TBL] [Abstract][Full Text] [Related]
4. [Clinico-scintigraphic studies of bone disease (renal osteodystrophy) in patients on chronic hemodialysis (preliminary report)].
Ionova D; Garcheva M; Simeonova A; Kiriakov Z
Vutr Boles; 1988; 27(2):107-12. PubMed ID: 2842966
[TBL] [Abstract][Full Text] [Related]
5. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.
Fletcher S; Jones RG; Rayner HC; Harnden P; Hordon LD; Aaron JE; Oldroyd B; Brownjohn AM; Turney JH; Smith MA
Nephron; 1997; 75(4):412-9. PubMed ID: 9127327
[TBL] [Abstract][Full Text] [Related]
6. Effects of renal failure and metabolic diseases upon bone scanning in children.
Schümichen C
Ann Radiol (Paris); 1983; 26(6):498-504. PubMed ID: 6316830
[No Abstract] [Full Text] [Related]
7. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S
Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
[TBL] [Abstract][Full Text] [Related]
8. Abnormal 99mTechnetium-tin-pyrophosphate bone scans in chronic renal failure.
Lien JW; Wiegmann T; Rosenthall L; Kaye M
Clin Nephrol; 1976 Dec; 6(6):509-12. PubMed ID: 188582
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of 99mTc pyrophosphate bone scintigraphy in the survey of dialysis osteodystrophy.
Vanherweghem JL; Schoutens A; Bergman P; Dhaene M; Goldman M; Fuss M; Kinnaert P
Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():431-4. PubMed ID: 2986102
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of 99mTc pyrophosphate bone scintigraphy for vitamin D trials in uraemia.
Vanherweghem JL; Dhaene M; Tielemans C; Dratwa M; Verbanck P; Bergmann P; Schoutens A; Fuss M
Proc Eur Dial Transplant Assoc; 1981; 18():648-51. PubMed ID: 6276883
[TBL] [Abstract][Full Text] [Related]
11. Imaging of bone in the diagnostics of renal osteodystrophy in children with chronic renal failure.
Ziółkowska H; Pańczyk-Tomaszewska M; Majkowska Z; Rajkowski T; Debiński A; Przedlacki J; Sawicki A; Ostrowski K; Marciński A; Roszkowska-Blaim M
Med Sci Monit; 2001; 7(5):1034-42. PubMed ID: 11535955
[TBL] [Abstract][Full Text] [Related]
12. Bone scan in chronic dialysis patients with evidence of secondary hyperparathyroidism and renal osteodystrophy.
Sy WM; Mittal AK
Br J Radiol; 1975 Nov; 48(575):878-84. PubMed ID: 1218297
[TBL] [Abstract][Full Text] [Related]
13. [Radionuclide studies in chronically hemodialyzed patients. Bone scintigraphy for the evaluation and control of renal osteopathy].
Dudczak R; Kletter K; Czembirek H; Derfler K; Marosi L; Salomonowitz E; Schmidt P; Wurzer G; Zazgornik J
Wien Klin Wochenschr; 1984 Apr; 96(9):326-32. PubMed ID: 6236616
[TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis between secondary hyperparathyroidism and aluminum intoxication in uremic patients: usefulness of 99mTc-pyrophosphate bone scintigraphy.
Kinnaert P; Van Hooff I; Schoutens A; Bergmann P; Fuss M; Dratwa M; Vienne A; Pasteels JL; van Geertruyden J; Vanherweghem JL
World J Surg; 1989; 13(2):219-23; discussion 223-4. PubMed ID: 2543146
[TBL] [Abstract][Full Text] [Related]
15. [Importance of bone scanning with Tc 99m in the supervision of hemodialysis patients with chronic renal failure (author's transl)].
Kessler M; Ferry JP; Naoun A; Robert J; Huriet C
Nephrologie; 1981; 2(4):171-5. PubMed ID: 7329502
[TBL] [Abstract][Full Text] [Related]
16. [A pathological analysis of 51 cases of renal osteodystrophy].
Yu YF; Hu YX; Zhu P
Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):448-50. PubMed ID: 8275821
[TBL] [Abstract][Full Text] [Related]
17. Value of the 99mTc-methylene diphosphonate bone scan in renal osteodystrophy.
Karsenty G; Vigneron N; Jorgetti V; Fauchet M; Zingraff J; Drüeke T; Cournot-Witmer G
Kidney Int; 1986 May; 29(5):1058-65. PubMed ID: 3723927
[TBL] [Abstract][Full Text] [Related]
18. Assessment of osteodystrophy in patients with chronic renal failure.
Brown DJ; Dawborn JK; Thomas DP; Xipell JM
Aust N Z J Med; 1982 Jun; 12(3):250-4. PubMed ID: 6956291
[TBL] [Abstract][Full Text] [Related]
19. [Metastatic calcifications as demonstrated by technetium-99m-pyrophosphate bone scanning. Case reports].
Louw NW; Klopper JF; van Heerden PD
S Afr Med J; 1982 Oct; 62(17):617-20. PubMed ID: 6289479
[TBL] [Abstract][Full Text] [Related]
20. A clinical assessment of the relationship between bone scintigraphy and serum biochemical markers in hemodialysis patients.
Kurata S; Ishibashi M; Nishida H; Hiromatsu Y; Hayabuchi N
Ann Nucl Med; 2004 Sep; 18(6):513-8. PubMed ID: 15515752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
